Kidney Cancer

The use of robotic tumor enucleation conferred favorable long-term surgical margins and local recurrence rates in patients with sporadic renal cell carcinoma (RCC), according to the results of a single-center Italian study.1 The findings were published online September 27, 2018, in Urologic Oncology. Patients undergoing robotic tumor enucleation with no ablation of the tumor bed…

Percutaneous microwave ablation (MWA) is a promising treatment strategy for patients with cT1-stage renal tumors, but more research into patient risk stratification and selection is needed.

A review is presented of adverse events common with 5 oral chemotherapy drugs used to treat renal cell carcinoma.